Gene: CNTD1
Official Full Name: cyclin N-terminal domain containing 1provided by HGNC
Gene Summary: Predicted to be involved in reciprocal meiotic recombination and regulation of meiotic cell cycle. Predicted to act upstream of or within spermatogenesis. Predicted to be located in chromosome. Predicted to be active in site of double-strand break. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27965 | CNTD1 Knockout cell line (HeLa) | Human | CNTD1 | 1:3~1:6 | Negative | Online Inquiry |
KO27966 | CNTD1 Knockout cell line (HCT 116) | Human | CNTD1 | 1:2~1:4 | Negative | Online Inquiry |
KO27967 | CNTD1 Knockout cell line (A549) | Human | CNTD1 | 1:3~1:4 | Negative | Online Inquiry |
CNTD1 Gene Knockout Cell Lines represent a significant advancement in the field of genetic research, specifically designed to facilitate the study of CNTD1 gene function. These cell lines have been meticulously engineered to feature a complete knockout of the CNTD1 gene, enabling researchers to elucidate the gene’s role in various biological processes and disease mechanisms. By creating a model system that lacks the expression of CNTD1, investigators can observe the phenotypic and molecular changes that arise in its absence, making it an invaluable tool for functional genomics.
The key function of CNTD1 Gene Knockout Cell Lines lies in their ability to provide clear insights into the pathways influenced by CNTD1. These cell lines operate via the precise mutation and disruption of CNTD1, utilizing advanced CRISPR-Cas9 technology, which ensures high fidelity and efficiency in gene editing. This specificity allows for unequivocal assessments of gene function, paving the way for targeted therapeutic developments and enhancing our understanding of CNTD1’s contribution to cellular processes such as growth, differentiation, and stress responses.
From a scientific standpoint, the applications of CNTD1 Gene Knockout Cell Lines are vast. They are crucial in both academic and clinical research settings, where they serve as models for drug discovery, disease modeling, and pathway analysis. The availability of these knockout lines can significantly expedite the development of novel therapeutic strategies targeting dysfunctions associated with CNTD1.
What sets CNTD1 Gene Knockout Cell Lines apart is their unparalleled quality and reliability. Each line is thoroughly validated for gene knockout efficiency and consistent phenotypic traits, ensuring reproducibility across experiments. Furthermore, they are easily adaptable for high-throughput screening and compatibility with various assays, making them a preferred choice among researchers.
For scientists and clinicians seeking to explore the complexities of gene function and disease mechanistics, CNTD1 Gene Knockout Cell Lines offer an essential resource. Their ability to accurately mimic conditions for experimental studies is vital for translating findings into clinical relevance. Our company is dedicated to advancing scientific research through innovative biotechnological solutions, and our CNTD1 Gene Knockout Cell Lines epitomize our commitment to providing high-quality, accessible research tools to empower breakthroughs in genetic research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.